Biased search
Publication bias is making antidepressants look like a better option for treating autism than they really are, according to a study published last week in Pediatrics.
Publication bias is making antidepressants look like a better option for treating autism than they really are, according to a study published last week in Pediatrics.
A promising approach to treating fragile X syndrome could benefit people even after the critical window of early brain development, and alleviate core symptoms of autism, according to two studies published this month.
Aripiprazole, a drug approved by the U.S. Food and Drug Administration to treat irritability in children with autism, may also improve their overall health-related quality of life, according to a retrospective analysis of two clinical trials. The results were published 21 March in Clinical Therapeutics.
Early intensive intervention is the only therapy that has been shown to be effective in young children with autism, according to a 2011 review of autism treatments commissioned by the U.S. Agency for Healthcare Research and Quality. But researchers are just beginning to tease out what they refer to as its ‘active ingredients:’ why the treatment works, which elements are essential and why it fails to help some children.
A new clinical trial, conducted entirely online, could provide a model for how to quickly and efficiently test some potential treatments for autism.
The French documentary Le Mur (The Wall) shows that many psychoanalysts in France shun biological explanations for autism.
A new meta-analysis shows that less than two percent of participants in studies of behavioral interventions for autism are adults.
Researchers have identified a new mechanism that may underlie a runaway cell signaling pathway in fragile X syndrome. The results were published 22 January in Nature Neuroscience.
Mice engineered to carry a Rett syndrome mutation only in neurons are prone to an irregular heartbeat that can lead to sudden death, according to a study published 14 December in Science Translational Medicine.
A new microscope allows researchers to capture the movement of tiny signal-receiving branches in the brains of adult mice at the nanoscale level. The results were published 3 February in Science.